Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Post-operative Effectiveness and Morbidity of Rezum Therapy for Benign Prostatic Hyperplasia

NCT05982444 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT05982444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05982444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Post-operative Effectiveness and Morbidity of Rezum Therapy for Benign Prostatic Hyperplasia
Lead sponsor
Helwan University
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
May 1, 2025
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, lower urinary track symptoms